Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Cord Blood Cells for BPD Prevention in Preterm Neonates
NCT04311476Phase 2Completed
- Start
- Jul 2018
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous umbilical cord blood-derived mononuclear cells in bronchopulmonary dysplasia (BPD). Started Jul 2018; status: completed.
02
Drugs
autologous umbilical cord blood-derived mononuclear cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT04311476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04311476.